The Burning Question About Inflammation: Are Cannabinoids the Cure?

By | August 4, 2017

 

FREE Webinar

Thursday, September 28, 2017
2:30 - 4:00 PM EDT
Register Now

Simmering, low-level inflammation throughout the body is responsible for many disease processes, ranging from osteoarthritis and cardiovascular disease, to digestive disorders and neurodegeneration. The bioactive molecules, known as cannabinoids, found in plants of the Cannabis species, have been shown to possess powerful anti-inflammatory attributes, and research into their mechanisms of action, efficacy, and tolerability are underway. To explore the potential for cannabinoid-based and/or endocannabinoid-targeted therapeutics in the realm of human disease, and particularly diseases with an inflammatory component, The Scientist is bringing together a panel of experts to discuss their research, and to offer insight into the rewards and challenges of studying a biomedical application for a well-known, but controlled, substance. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • Exogenous and endogenous cannabinoid mechanisms of action in the setting of inflammatory disease
  • Targeting the endocannabinoid system for therapeutic effects

Register Now

 

Meet the Speakers:

Anton Reiner, PhD  
Professor, Department of Anatomy and Neurobiology
University of Tennessee Health Science Center

 

 

Yannick Marchalant, PhD  
Assistant Professor, Departments of Psychology and Neuroscience
Central Michigan University

 

 

 

 

 

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: dmarciani

dmarciani

Posts: 46

July 19, 2017

Experimental evidence has clearly shown that certain fucosylated glycans by binding DC-SIGN induce a Th2 anti-inflammatory immunity while inhibiting, but not abrogating the pro-inflammatory Th1/Th17. In fact, a strategy successfully used by certain parasites to prevent the host’s damaging proinflammatory response. I will be quite interested in learning why cannabinoids are superior to the fucosylated glycans? Epidemiological data also shows that proteopathies, like Alzheimer’s disease and autoimmune diseases, caused by inflammatory immune responses, are quite diminished by infection with those parasites. At the risk of being accused of skepticism, I wonder why cannabinoids are now instant celebrities, while fucosylated glycans that have been doing efficiently the same job for millions of years are not. Indeed, in mammals the prevention of fetal rejection and certain cancers’ evasion of immune surveillance are both mediated by fucosylated glycans.    

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS